BioNTech to pay $1.2 billion over vaccine royalties
BioNTech Enters Into Settlements With U.S. Agency, UPenn Over COVID-19 Vaccine Royalties
Concurrently, the company has amended its license agreements to provide for a low single-digit percentage royalty on Net Sales of Licensed Products for 2024 onwards. Currently, BioNTech's stock is trading at $114.25, up 0.42 percent on the Nasdaq.
BioNTech Settles Royalty Dispute with University of Pennsylvania
BioNTech SE has reached a settlement agreement with the University of Pennsylvania over a royalty dispute related to its COVID-19 vaccine, developed in collaboration with Pfizer. The agreement involves a payment of up to $467 million to Penn,
BioNTech SE ADR closed $17.54 below its 52-week high ($131.49), which the company achieved on September 17th.
BioNTech SE ( (BNTX) ) has provided an update. BioNTech SE has settled a dispute with the National Institutes of Health (NIH) regarding royalties allegedly owed on sales of its COVID-19 vaccine, ...
Tidal Investments LLC lessened its stake in BioNTech SE (NASDAQ:BNTX – Free Report) by 39.5% in the third quarter, ...
The ADR's fall snapped a three-day winning streak.
Hosted on MSN20d
Is BioNTech SE (BNTX) the Best German Stock to Buy Now?In this article, we are going to take a look at where BioNTech SE (NASDAQ:BNTX) stands against the other German stocks. In Germany, the economic growth is based on industry. According to ...
BioNTech SE (NASDAQ:BNTX – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seventeen ...
In a report released on December 6, Daina Graybosch from Leerink Partners maintained a Buy rating on BioNTech SE (BNTX – Research Report), with ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
BNT-321 is under clinical development by BioNTech and currently in Phase I for Pancreatic Ductal Adenocarcinoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback